These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 728887)

  • 41. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: single fraction heat and drug treatment.
    Monge OR; Rofstad EK; Kaalhus O
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1661-9. PubMed ID: 3145205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental chemotherapy against canine mammary cancer xenograft in SCID mice and its prediction of clinical effect.
    Yamashita A; Maruo K; Suzuki K; Shirota K; Kobayashi K; Hioki K
    J Vet Med Sci; 2001 Aug; 63(8):831-6. PubMed ID: 11558535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Siim BG; Lee AE; Shalal-Zwain S; Pruijn FB; McKeage MJ; Wilson WR
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):43-52. PubMed ID: 12497205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of bleomycin on survival and tumor growth in a C3H mouse mammary carcinoma.
    Urano M; Fukuda N; Koike S
    Cancer Res; 1973 Nov; 33(11):2849-55. PubMed ID: 4127106
    [No Abstract]   [Full Text] [Related]  

  • 45. [Attempts at synchronization of phase S with anticancer chemotherapy].
    Duprez A; Bessot M
    Bull Cancer; 1968; 55(1):75-86. PubMed ID: 5702313
    [No Abstract]   [Full Text] [Related]  

  • 46. Combined treatment with radioestradiol-lucanthone in mouse C3HBA mammary adenocarcinoma and with estradiol-lucanthone in an estrogen bioassay.
    Padawer J; Rettura G; Thysen B; Gatz M; Seifter E
    Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):349-57. PubMed ID: 7275712
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro effects of methotrexate, 5-fluorouracil, cyclophosphamide and vincristine sulphate on the metabolism of induced mammary cancers in rats.
    de Loecker W; van der Schueren G
    Eur J Cancer (1965); 1978 Dec; 14(12):1363-8. PubMed ID: 738340
    [No Abstract]   [Full Text] [Related]  

  • 48. [Improving the anti-tumor activity of 5-fluorouracil by methotrexate].
    Konishi T; Noie T; Abe T; Agawa S; Furushima K; Ito K; Mafune K; Makuuchi M; Teruya M; Nouchi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):431-9. PubMed ID: 10097739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM; Otter GM; Schmid FA
    Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of magnesium, calcium and vitamin C on tumor growth in mice with breast cancer.
    Frazier TG; McGinn ME
    J Surg Res; 1979 Nov; 27(5):318-20. PubMed ID: 513697
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of methotrexate upon tumour ATP as determined by in vivo 31P inversion spin transfer.
    Haseler LJ; Irving MG; Doddrell DM
    NMR Biomed; 1988 Jun; 1(3):127-30. PubMed ID: 3275123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer chemotherapy: past is prologue.
    Martin DS
    Mt Sinai J Med; 1985 Jun; 52(6):426-34. PubMed ID: 3875021
    [No Abstract]   [Full Text] [Related]  

  • 55. Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
    Bennett A; Berstock DA; Carroll MA
    Br J Cancer; 1982 May; 45(5):762-8. PubMed ID: 7082558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sequential methotrexate and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The increased cytotoxicity in colon adenocarcinoma of methotrexate-5-fluorouracil is not associated with increased induction of lesions in DNA by 5-fluorouracil.
    Lönn U; Lönn S
    Biochem Pharmacol; 1986 Jan; 35(2):177-81. PubMed ID: 3942594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice.
    Penhaligon M; Camplejohn RS
    J Natl Cancer Inst; 1985 Apr; 74(4):869-73. PubMed ID: 3857381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronology of combined chemotherapy (5FU) and radiotherapy. II. In vivo study.
    Demange L; Carpentier Y; Loirette M; Hivet J; Rigaud C; Desoize B
    Anticancer Res; 1993; 13(6A):2181-6. PubMed ID: 8297132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.